- Beam Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Beam Therapeutics Inc at Citi BioPharma Conference TranscriptSep 07, 2023
- Beam Therapeutics Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) TranscriptMay 30, 2023
- Beam Therapeutics Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Beam Therapeutics Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) TranscriptApr 03, 2023
- Beam Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2023
- Beam Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Beam Therapeutics Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Beam Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Beam Therapeutics Inc at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Beam Therapeutics Inc Annual Shareholders Meeting TranscriptJun 08, 2022
- Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Beam Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Beam Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Beam Therapeutics Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 27, 2021
- Beam Therapeutics Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2021
- Beam Therapeutics Inc at William Blair Biotech Focus Conference (Virtual) TranscriptJul 15, 2021
- Beam Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
Beam Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Good afternoon. My name is Gena Wang. I'm SMid-Cap Biotech Analyst at the Barclays. Welcome to our second Virtual Global Healthcare Conference. First, I wish everyone stay healthy, and I would like to thank all the participants, investors and companies and especially our event team and our corporate access team who made this virtual healthcare conference possible. And with that, I would like to introduce our next presenter, John Evans from Beam. John, I hand over to you.
Great. Thank you, Gena, and hello, everybody. Great to be with you. So let me bring up some slides that I think will help us introduce the Beam story, and then we'll close that down and go into a Q&A, which I think will be hopefully quite illuminating.
So Beam is really a next generation of technology in gene editing. And the goal here is really to improve our ability to make precise changes in genes that could be potentially curative and do so without
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)